|
Santa Cruz Biotechnology
mouse anti nfatc1 Mouse Anti Nfatc1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+nfatc1/NFATc1+Antibody/pm41596482-255-17-20 Average 96 stars, based on 1 article reviews
mouse anti nfatc1 - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
Proteintech
mouse anti nfatc 1 Mouse Anti Nfatc 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+nfatc1/NFATC1+Antibody/pm41365188-57-25-31 Average 95 stars, based on 1 article reviews
mouse anti nfatc 1 - by Bioz Stars,
2026-10
95/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
sc 7294 mouse anti cathepsin k Sc 7294 Mouse Anti Cathepsin K, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+nfatc1/NFATc1+Antibody/10__1002_slash_adfm__202509193-96-38-36 Average 96 stars, based on 1 article reviews
sc 7294 mouse anti cathepsin k - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
sc 393325 mouse anti nfatc1 Sc 393325 Mouse Anti Nfatc1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+nfatc1/OSX+Antibody/10__1002_slash_adfm__202509193-96-32-30 Average 96 stars, based on 1 article reviews
sc 393325 mouse anti nfatc1 - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mouse anti nfatc1 primary antibody ![]() Mouse Anti Nfatc1 Primary Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+nfatc1/NFATc1+Antibody/pmc12248284-267-35-39 Average 96 stars, based on 1 article reviews
mouse anti nfatc1 primary antibody - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mouse monoclonal anti nfatc1 ![]() Mouse Monoclonal Anti Nfatc1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+nfatc1/NFATc1+Antibody/pmc11762708-7-2-6 Average 96 stars, based on 1 article reviews
mouse monoclonal anti nfatc1 - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
resource source identifier antibodies mouse monoclonal anti nfatc1 santa cruz ![]() Resource Source Identifier Antibodies Mouse Monoclonal Anti Nfatc1 Santa Cruz, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+nfatc1/NFATc1+Antibody/pm39720522-180-2-9 Average 96 stars, based on 1 article reviews
resource source identifier antibodies mouse monoclonal anti nfatc1 santa cruz - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
Journal: Science Advances
Article Title: Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis
doi: 10.1126/sciadv.ads3829
Figure Lengend Snippet: ( A ) Intracellular cAMP levels in WT BMM cells after induction with RANKL (100 ng/ml), DMSO, or GL64 (30 μM). The data are presented as the means ± SD. ** P < 0.01. Two independent biological replicates were performed. ( B ) Intracellular cAMP levels in vector- and ADGRD1 -overexpressing RAW264.7 cells. The data are presented as the means ± SD. * P < 0.05. Four independent biological replicates were performed. ( C ) Representative images of TRAP staining of BMMs treated with DMSO, GL64 (10 μM), or H89 (1 μM) and stimulated with RANKL (100 ng/ml) for 6 days. Scale bars, 50 μm. ( D ) Quantification of osteoclast area and number shown in (C) (area: F 3,6 = 45.34, P = 0.0002; number: F 3,6 = 69.20, P < 0.0001). The data are presented as the means ± SD. ** P < 0.01 and *** P < 0.001. Three independent biological replicates were performed. ( E ) Representative TRAP staining images of WT and Adgrd1 −/− BMMs treated with RANKL (100 ng/ml) or IBMX (50 μM) for 6 days. Scale bars, 50 μm. ( F ) Quantification of the osteoclast area (top) and number (bottom) of the cells shown in (E) (area: F 3,6 = 30.08, P = 0.0005; number: F 3,6 = 291.4, P < 0.0001). The data are presented as the means ± SD. * P < 0.05 and *** P < 0.001. Three independent biological replicates were performed. ( G ) Representative images of NFATC1 nuclear translocation in BMM cells treated with DMSO, GL64 (10 μM), or H89 (1 μM) and stimulated with RANKL (100 ng/ml) for 2 days. Scale bars, 50 μm. ( H ) Percentage of NFATC1 nuclear localization in the samples shown in (G) ( F 3,6 = 34.52, P = 0.0004). Data are presented as the means ± SD. * P < 0.05. Three independent biological replicates were performed.
Article Snippet: After being removed from the medium and washed three times with PBS, the slides were fixed with 4% formaldehyde, permeabilized with 0.1% Triton X-100, blocked with 5% bovine serum albumin, and then incubated with a
Techniques: Plasmid Preparation, Staining, Translocation Assay
Journal: Biology
Article Title: FAM98 Family Proteins Play Distinct Roles in Osteoclastogenesis and Bone Resorption
doi: 10.3390/biology14010045
Figure Lengend Snippet: The key reagents used in this study.
Article Snippet: Antibodies ,
Techniques: Red Blood Cell Lysis, Plasmid Preparation, Transduction, Transfection, Staining, Lysis, Protease Inhibitor, Purification, Gene Expression, Quantitative RT-PCR
Journal: iScience
Article Title: Peroxiredoxin 1-Toll-like receptor 4-p65 axis inhibits receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation.
doi: 10.1016/j.isci.2024.111455
Figure Lengend Snippet: Figure 2. Gene profiling analysis of PRDX1 during osteoclastogenesis (A) The period for osteoclast differentiation was divided into four distinct time periods (T1 to T4). PRDX1 (200 nM) was treated during each period, and TRAP- positive multinucleated cells were counted. (B) Heatmap shows mRNA expression profiles of PRDX1 during osteoclastogenesis. K-means (K = 5) clustering of 4,328 differentially expressed genes (DEGs) in any pairwise comparison among four conditions (left panel). The clusters are indicated on the left. The right panel shows a heatmap showing the P-value sig- nificance and gene numbers of gene ontology (GO) analysis for genes in each cluster. (C) GSEA plot shows the increased gene expression of cell surface toll-like receptor signaling pathway in PRDX1 (PRDX1 + no RANKL condition) compared to control (no PRDX1 + no RANKL). Cfb and Ccl5 expression levels were measured by RT-qPCR using specific primers. (D) GSEA plot shows the decreased gene expression of the regulation of osteoclast differentiation in PRDX1 + RANKL treatment compared to RANKL treatment. mRNA expression levels of Ctsk, Dcstamp, and Nfatc1 were measured by RT-qPCR. The data are presented as the mean ± SD values from three independent experiments; P-value was examined by one-way ANOVA with Tukey’s multiple comparisons test. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Article Snippet: REAGENT or
Techniques: Expressing, Comparison, Gene Expression, Control, Quantitative RT-PCR
Journal: iScience
Article Title: Peroxiredoxin 1-Toll-like receptor 4-p65 axis inhibits receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation.
doi: 10.1016/j.isci.2024.111455
Figure Lengend Snippet: Figure 4. p65 is the transcription factor for PRDX1-TLR4 signaling (A) The most significantly enriched transcription factors regulating PRDX1 target genes belonging to cluster 4 (Figure 2B) using TRRUST v2. (B) Saa3 and Acod1 expression levels were measured from OCP cells treated with JSH23 (20 mM) in the presence of PRDX1 (200 nM). (C) OCP cells were treated with PRDX1 (200 nM) at the indicated times. Nuclear translocation of p65 was analyzed by immunoblotting with p65 antibody. The immunoblot band was quantified using ImageJ software and normalized to lamin C band intensity. (D) ChIP assay of p65 occupancy at the Saa3 and Acod1 promoters after 30 min of PRDX1 (200 nM) treatment. (E) OCP cells were treated with a combination of PRDX1 (200 nM) and RANKL (100 ng/mL) as indicated. Nuclear extracts were analyzed by immunoblotting for p65. The immunoblot band intensity was quantified using ImageJ software and normalized to lamin C band intensity. (F) ChIP assay of p65 occupancy at the Saa3, Acod1, and Nfatc1 promoters with a combination of PRDX1 (200 nM) and RANKL (100 ng/mL) for 30 min. (G) mRNA expression levels of Saa3, Acod1, and Nfatc1 treated with PRDX1 (100 and 200 nM) and/or RANKL (100 ng/mL) for 1 day. The data were presented as Mean ± SD from three independent experiments. p value is determined by a two-tailed t-test in (D) and one-way ANOVA with Tukey’s multiple comparisons test in (B, C, E, and, F). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Article Snippet: REAGENT or
Techniques: Expressing, Translocation Assay, Western Blot, Software, Two Tailed Test
Journal: iScience
Article Title: Peroxiredoxin 1-Toll-like receptor 4-p65 axis inhibits receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation.
doi: 10.1016/j.isci.2024.111455
Figure Lengend Snippet: Figure 6. Model represents PRDX1-TLR4 signaling redirecting p65 to the Saa3 and Acod1 promoters rather than the Nfatc1 promoter (A) RANKL-RANK signaling pathway: RANKL binding to RANK activates p65, which translocates to the nucleus and binds to the Nfatc1 promoter, inducing osteoclastogenesis. (B) PRDX1-TLR4 signaling pathway: Activation of PRDX1-TLR4 signaling redirects p65 to the promoter regions of Saa3 and Acod1 instead of Nfatc1. As a result, PRDX1 induces the expression of Saa3 and Acod1 during RANKL-mediated osteoclast differentiation. The increase in SAA3 and itaconate, produced by ACOD1, inhibits osteoclast differentiation.
Article Snippet: REAGENT or
Techniques: Binding Assay, Activation Assay, Expressing, Produced